Ascent Group, LLC Bristol Myers Squibb CO Transaction History

Ascent Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $267,111 - $302,964	-4,065 Reduced 36.49%	7,075 $490,000
Q4 2022 Feb 16, 2023	SELL	$68.48 - $81.09 $366,504 - $433,993	-5,352 Reduced 32.45%	11,140 $801,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $539 - $318,732	4,148 Added 33.6%	16,492 $1.28 Million
Q2 2022 Aug 05, 2022	BUY	$72.62 - $79.98 $17,646 - $19,435	243 Added 2.01%	12,344 $911,000
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $184,194 - $220,865	2,996 Added 32.9%	12,101 $884,000
Q4 2021 Mar 01, 2022	BUY	$53.63 - $62.52 $488,301 - $569,244	9,105 New	9,105 $579,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Ascent Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Ascent Group, LLC with notifications on news.